生命尽头的临床试验
总计419291个结果
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
National Cancer Centre, SingaporeBristol-Myers Squibb撤销
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的B-cell Lymphoid Leukemia | Young Patients意大利
-
National Research Center for Hematology, Russia主动,不招人
-
Bristol-Myers Squibb终止
-
Eli Lilly and CompanyARMO BioSciences终止
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; San Francisco Hep B Free Campaign完全的
-
Columbia University完全的霍奇金淋巴瘤 | 间变性大细胞淋巴瘤加拿大, 美国
-
Accuray IncorporatedM.D. Anderson Cancer Center终止
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)完全的
-
Wake Forest University Health Sciences完全的
-
University Hospital, GrenobleBristol-Myers Squibb完全的
-
Nilogen OncosystemsHenry Ford Health System未知
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Peking University People's Hospital; Peking Union Medical College... 和其他合作者未知
-
Institut de Cancérologie de Lorraine完全的
-
ADC Therapeutics S.A.终止
-
Marks Colorectal Surgical Associates未知
-
The First Affiliated Hospital with Nanjing Medical...未知
-
Tongji HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
National Cancer Institute (NCI)完全的非小细胞肺癌美国, 墨西哥, 玻利维亚, 秘鲁, 委内瑞拉
-
Michael ChoiThe Leukemia and Lymphoma Society终止
-
The First Affiliated Hospital with Nanjing Medical...Xian-Janssen Pharmaceutical Ltd.未知
-
José Antonio CarrionInstituto de Salud Carlos III完全的慢性乙型肝炎(HBeAg 阴性)
-
Tianjin Medical University Cancer Institute and...未知
-
Kawin Technology Share-holding Co., Ltd.KawinGreen Biotech Co., Ltd.完全的
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Cellectar Biosciences, Inc.完全的